Cancer Institute of New Jersey At Hamilton — Hamilton, New Jersey

Cancer Institute of New Jersey At Hamilton is a clinical research site located in Hamilton, New Jersey, United States 08690.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Cancer Institute of New Jersey At Hamilton has participated in 7 clinical trials.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, NSABP Foundation Inc, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Institute of New Jersey At Hamilton?

Cancer Institute of New Jersey At Hamilton has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Institute of New Jersey At Hamilton conducted?

Cancer Institute of New Jersey At Hamilton has 7 clinical trials on record. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Cancer Institute of New Jersey At Hamilton accredited by Crixeo Health?

Yes — Cancer Institute of New Jersey At Hamilton holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cancer Institute of New Jersey At Hamilton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.